Finch Therapeutics Group, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| SMISEK JEFFERY A | — | Gift | 383 | — | — | 24,383 | Jun 7, 2024 |
| SMISEK JEFFERY A | — | Gift | 3,750 | — | — | — | May 20, 2024 |
| SMISEK JEFFERY A | — | Sale | 1,600 | $2.61 | $4,176 | 6,512 | Mar 28, 2024 |
| SMISEK JEFFERY A | — | Sale | 1,470 | $3.64 | $5,351 | 6,642 | Nov 22, 2023 |
| Graf Susan E | — | Purchase | 5,010 | $0.27 | $1,353 | 5,010 | Jun 9, 2023 |
| Blaustein Marc | Chief Operating Officer | Sale | 4,619 | $0.38 | $1,755 | 27,995 | Feb 21, 2023 |
| Blaustein Marc | Chief Operating Officer | Sale | 3,636 | $1.39 | $5,054 | 32,614 | Oct 21, 2022 |
| Vittiglio Joseph | Chief Business & Legal Officer | Sale | 3,636 | $1.39 | $5,054 | 31,364 | Oct 21, 2022 |
| Blaustein Marc | Chief Operating Officer | Award / Grant | 35,000 | — | — | 36,250 | Jun 13, 2022 |
| Vittiglio Joseph | Chief Business & Legal Officer | Award / Grant | 35,000 | — | — | 35,000 | Jun 13, 2022 |
| Haft Nicholas | — | Purchase | 63,850 | $10.18 | $649,993 | 4,056,907 | Dec 20, 2021 |
| SMISEK JEFFERY A | — | Purchase | 88,235 | $17.00 | $1,499,995 | 1,694,541 | Mar 23, 2021 |
| Haft Nicholas | — | C | 172,942 | — | — | 172,942 | Mar 23, 2021 |
| FERRANTE DOMENIC J | — | C | 141,928 | — | — | 141,928 | Mar 23, 2021 |
| Crestovo Investor LLC | — | Purchase | 735,294 | $17.00 | $12,499,998 | 12,641,441 | Mar 23, 2021 |